The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 3, 2004, Pages 575-582

  Na Bangchang, K ^a   Krudsood, S ^b   Silachamroon, U ^b   Molunto, P ^b   Tasanor, O ^a   Chalermrut, K ^b   Tangpukdee, N ^b   Matangkasombut, O ^c   Kano, S ^d   Looareesuwan, S ^b,e  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c RANGSIT UNIVERSITY   (Thailand)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; DIHYDROARTEMISININ; TWISININ;

ADULT; ARTICLE; BIOTRANSFORMATION; BODY WEIGHT; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TRACT; HUMAN; KINETICS; MALE; NORMAL HUMAN; PHARMACOLOGICAL PARAMETERS; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; THAILAND;

EID: 20844440700     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barradell LB, Fitton A. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 1995; 50: 714-41.
2. Basco L, Le bras J. In vitro activity of artemisinin derivatives against African siolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 1993; 49: 301-7.
3. Batty KL, Le AT, Ilett KF, et al. A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria. Am J Trop Med Hyg 1998a; 59: 823-7.
4. Batty KT, Thu LT, Davis TME, et al. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria. Br J Clin Pharmacol 1998b; 45: 123-29.
5. Berman JG, Egan A, Keusch GT. The intolerable burden of malaria: a new look at the numbers. Am J Trop Med Hyg 2001; 64 (suppl): 4-7i.
6. Binh TQ, Ilett KF, Batty KT, et al. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. Br J Clin Pharmacol 2001; 51: 541-6.
7. de Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 1996; 52: 818-6.
8. th ed. Philadelphia: Lea and Febriger, 1991: 14-23.
9. Harinasuta T, Karbwang J. Qinghaosu: a promising antimalarial. JAMA 1994; 34: 7.
10. Hein TT, White NJ. Qinghaosu. Lancet 1993; 341: 603-8.
11. Hung LN, Na-Bangchang K, Thuy LTD, Anh TK, Karbwang J. Pharmacokinetics of a single oral dose of dihydroartemisinin in Vietnamese healthy volunetters. Southeast Asian J Trop Med Public Health 1999; 30: 11-6.
12. Ilett KF, Batty KT, Powell SM, et al. The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria. Br J Clin Pharmacol 2002; 53: 23-30.
13. Lee IS, Hufford CD. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther 1990; 48: 345-5.
14. Lin AJ, Klayman DL, Milhous WK. Antimalarial activity of new water-soluble dihydroartemisinin derivatives. J Med Chem 1987; 30: 2147-50.
15. Looareesuwan S, Wilairatana R, Andrial M. Artesunate suppository for treatment of severe falciparum malaria in Thailand. Jpn J Trop Med Hyg 1996; 24 (suppl 1): 13-5.
16. McIntosh HM, Olliaro P. Treatment of severe malaria with artemisinin derivatives. A systematic review of randomised controlled trials. Med Trop 1998; 58 (suppl): 61-2.
17. Maggs JL, Madden S, Bishop LP, O'Neil PM, Park BK. The rat biliary metabolites of dihydroartemisinin, an antimalarial endoperoxide. Drug Metab Dispos 1997; 25: 1200-04.
18. Na-Bangchang K, Congpuong K, Ubalee R, Thanavibul A, Tan-ariya P, Karbwang J. Pharmacokinetics and ex vivo antimalarial activity of sera following a single oral dose of dihydroartemisinin in healthy Thai males. Southeast Asian J Trop Med Public Health 1997; 28: 731-5.
19. Na-Bangchang K, Karbwang J, Congpoung K, Thanavibul A, Ubalee R. Pharmacokinetic and bioequi valence evaluation of two generic formulations of oral artesunate. Eur J Clin Pharmacol 1998a; 53: 375-6.
20. Na-Bangchang K, Congpoung K, Hung LN, Molunto P, Karbwang J. Simple high performance liquid chromatographic method with electrochemical detection for the simultaneous determination of artesunate and dihydroartemisinin in biological fluids. J Chromatogr B 1998b; 708: 201-7.
21. Na-Bangchang K, Tippawangkosol P, Thanavibul A, Ubalee A, Karbwang J. Pharmacokinetic and pharmacodynamic interactions of mefloquine and dihydroartmisinin. Int J Clin Pharm Res 1999; XIX: 9-17.
22. Navaratnam V, Mansor SM, Sit N, Grace JM, Li Q, Olliaro P. Pharmacokinetics of artemisinin-type of compounds. Clin Pharmacokinet 2000; 39: 255-70.
23. Newton PN, Angus BJ, Chierakul W, et al. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis 2003; 37: 7-16.
24. van Agtmael MA, Eggelte TA, van Boxtel CJ. Artemisinin drugs in the treatment of malaria: from medicinal herbs to registered medication. Trends Pharmacol Sci 1999; 20: 199-205.
25. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Trap 1994; 56: 143-56.
26. White NJ. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives. Trans R Soc Trop Med Hyg 1994; 88 (suppl 1): S41-S43.
27. Yang SD, Ma JM, Sun JH, Chen DX, Song ZY. Clinical pharmacokinetics of a new effective antimalarial artesunate, a qinghaosu derivative. Chin J Clin Pharmacol 1985; 1: 106-9.
28. Zhao KC, Chen ZX, Lin BL, Guo XB, Li GQ, Song ZY. Studies on the phase 1 clinical pharmacokinetics of artesunate and artemether. Chin J Clin Pharmacol 1988; 4: 76-81.